Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,995 | 137,750 | 56,522 | 58,304 | 63,212 |
| Receivables | 64 | 107 | 111 | 97 | 148 |
| TOTAL | $134,151 | $140,592 | $58,395 | $59,268 | $63,823 |
| Non-Current Assets | |||||
| PPE Net | 4,789 | 1,374 | 730 | 709 | 748 |
| Intangibles | 36,356 | 36,443 | 36,529 | 36,616 | 40,647 |
| Other Non-Current Assets | 357 | 357 | 77 | 66 | 66 |
| TOTAL | $41,502 | $38,174 | $37,336 | $37,391 | $41,461 |
| Total Assets | $175,653 | $178,766 | $95,731 | $96,659 | $105,284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,910 | 1,881 | 2,037 | 3,617 | 5,463 |
| Accrued Expenses | N/A | 512 | N/A | N/A | N/A |
| TOTAL | $6,454 | $5,607 | $2,639 | $4,219 | $6,065 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 544 | 3,214 | 602 | 602 | N/A |
| TOTAL | $N/A | $3,061 | $3,212 | $3,362 | $3,513 |
| Total Liabilities | $6,454 | $8,668 | $5,851 | $7,581 | $9,578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,892 | 1,889 | 1,871 | 1,611 | 1,610 |
| Common Shares | 472 | 469 | 409 | 403 | 403 |
| Retained earnings | -364,592 | -359,792 | -351,342 | -345,999 | -337,720 |
| TOTAL | $169,199 | $170,098 | $89,880 | $89,078 | $95,706 |
| Total Liabilities And Equity | $175,653 | $178,766 | $95,731 | $96,659 | $105,284 |